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INTRODUCTION
Medicinal plants are plant with intrinsic therapeutic properties 
either on the whole or in their parts. These therapeutic properties 
confer on them high medicinal value especially in developing 
countries where assess to modern health care remains a 
challenge for many individuals. Moreover, these easily assessable 
medicinal plants exhibit significant efficacy and tolerability with 
insignificant side effects (Okigbo et al., 2008; Adelanwa and 
Tijani, 2013; Omotoso et al., 2019a; Omotoso et al., 2019b). 
They have widespread distribution in different parts of the 
world, constitute vital component of natural plant biodiversity 
and are actively applied for variety of ethnopharmacological uses 
(Adelanwa and Tijani, 2013; Omotoso et al., 2020c; Omotoso 
et al., 2020d). One of such ethnopharmacological applications 
is their usage as antiproliferative or antitumor or anti-cancer 
agent. The application of medicinal plants as anti-proliferative 
or anti-tumor agent in the treatment of cancer is globally on 
the rise. According to Carraz et al., (2015) different medicinal 
plant species especially those commonly used for gastric and 
hepatic tissue related disorders also exhibit antiproliferative 
effects. Some examples of medicinal plants with documented 
anti-proliferative effect include Indigofera aspalathiodes (Kumar 
et al., 2012), Stemona collinsae (Manosrol et al., 2015), Annona 
muricata (Asare et al., 2015), Rosmarinus officinalis (Cattaneo 
et al., 2015), Bellis perennis and Concolculus galaticus (Karakas 
et al., 2015), Physalis peruviana (El-kenawy et al., 2015) and 
Ageratum conyzoides (Omotoso and Eze, 2019f).
Cissampelos owariensis (C. owariensis) is a tropical, climber or 
twiner plant found in certain parts of West African countries 
where it is actively applied in native traditional medicines 
(Akande et al., 2013). It belongs to the Menispermaceae 
family of plants which is composed of about 70 genera and 
over 400 other plant species. Its taxonomic classification 
includes phylum- Tracheophyta; class- Mangoliopsida; 
Assessment of the antiproliferative 
potential of Cissampelos owariensis 
(P. Beauv) methanolic extract in 
Wistar rats
Dayo Rotimi Omotoso1*, Uche Christiana Okwuonu2, 
Olayinka Simbiat Lawal2, Oluwasegun Davis Olatomide2
1Department of Human Anatomy, Redeemer’s University, Ede, Osun State, Nigeria, 2Department of Anatomy, 
Igbinedion University, Okada, Edo State, Nigeria
ISSN:	2075-6240
Copyright: © The authors. This article is open access and licensed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/4.0/) which permits unrestricted, use, distribution and reproduction in any medium, or format for any purpose, 
even commercially provided the work is properly cited. Attribution — You must give appropriate credit, provide a link to the license, and indicate if 
changes were made.
ABSTRACT
Cissampelos owariensis is a medicinal plant with a wide range of therapeutic uses.  In this study, the objective was to 
further assess its antiproliferative potential using cell proliferation and tumor suppressor markers. Solvent extraction 
of the plant leaves was done using methanol. Twenty (20) male albino Wistar rats were randomly divided into four 
groups 1–4 (n=5) and respectively administered with methanolic extracts of C. owariensis at 0, 100, 300 and 500 mg/kg 
for 30 days. After treatment, the hepatic tissues were processed and examined histologically and immunohistochemically 
for cell proliferation (Ki-67) and tumor suppressor (p53) proteins.  Immunoexpression of the proteins was quantified 
using image-J software, the data analyzed with SPSS version 20 and values compared using t-test and one-way analysis 
of variance. The histological results showed no significant variation in hepatic histomorphology of treated Groups 2–4 
relative to non-treated Group 1. However, the immunohisto chemical results showed significant (p< 0.05) down-
regulation in Ki-67 protein expression and a concomitant significant (p< 0.05) up-regulation in p53 protein expression 
in hepatic tissues of treated Groups 2–4 relative to non-treated Group 1.These inverse expression patterns of cell 
proliferation and tumor suppressor proteins following exposure to methanolic extracts of C. owariensis may suggest 
the antiproliferative potential of the plant extracts.
Keywords: Cissampelos owariensis, Antiproliferative potential, Wistar rats
Received: August 19, 2021
Revised: November 21, 2021
Accepted: November 23, 2021
Published: December 23, 2021
*Corresponding Author: 
Dayo Rotimi Omotoso1 
Email: dayohmts@gmail.com
Research Article
J	Phytol	 •	 2021	 •	 Vol	13	 	 179	
Omotoso et al.
order- Ranunculales; genus- Cissampelos and specie- owariensis 
(Ekeanyanwu et al., 2012). As a medicinal plant, different parts 
of C. owariensis especially the roots, leaves and rhizomes, have 
been applied for various ethnopharmacological uses. These 
include treatment of miscarriages and sterility, treatment of 
wounds, reproductive diseases especially female infertility, 
gastrointestinal diseases (like dysentery, diarrhoea and enteritis) 
headache and fever especially typhoid and malaria fevers 
(Abbiw, 1990; Neuwinger, 2000; Schmelzer, 2008; Erhirhie 
et al., 2015). However, there is virtually no information on the 
antiproliferative activity of the plant at the moment. This study 
was therefore aimed at assessing the anti-proliferative potential 
of methanolic extract of C. owariensis (P. Beauv.) based on the 
expression of molecular markers for cell proliferation and tumor 
suppression (Ki-67 and p53 proteins) in hepatic tissue of adult 
male Wistar rats following exposure to the plant extract.
MATERIALS AND METHODS
Collection and Authentication of Plant Material
Fresh C. owariensis plant was obtained from suburb of 
Okada community in Edo State of Nigeria and verified at the 
Department of Pharmacognosy, Igbinedion University, Okada, 
Edo State, Nigeria. The bulk quantity of the plant, sufficient 
for the study, was collected after the verification and prepared 
for extraction.
Preparation of Methanolic Extract of C. owariensis
The detached leaves of the plant were air-dried, pulverised into 
powdered form, weighed and macerated in methanol for 72 
hours with intermittent agitation. The preparation was filtered 
and evaporated to dryness using a rotary evaporator. The residue 
was allowed to cool, weighed and used as the methanolic extracts 
used for this study.
Experimental Protocols
This study involved 20 adult male Wistar rats weighing between 
150g - 180g. They were equally divided into four groups (1-4) 
comprising of five animals per group. Group 1 was administered 
with distilled water (5 mL/kg body weight) and represented the 
control group. Groups 2 - 4were administered with 100mg/kg, 
300 mg/kg and 500 mg/kg methanolic extract of C. owariensis 
respectively. The selected dosages of extracts for this study 
were considered safe without toxic effects (Ekeanyanwu et al., 
2012).Administration of methanolic extract of C. owariensis 
in this study was done orally using flexible orogastric gavage 
and lasted for thirty days. After the period of administration, 
experimental animals were sacrificed via and hepatic tissues 
harvested and processed.
Tissue Processing
The fixation of hepatic tissue of experimental animals was 
done using 10% Neutral Buffered Formalin. Further processing 
involved dehydration using ascending grades of alcohol (which 
include 70%, 90% and 100% alcohol for 30 minutes each) and 
clearing was done using xylene for 30minutes. After tissue 
processing, the hepatic tissues were embedded in molten 
paraffin and allowed to cool to form tissue blocks in preparatory 
for sectioning and staining.
Tissue Sectioning and Staining
Blocks of hepatic tissue were cut into sections by using rotary 
microtome set at 5µ and 3µ thickness and sections obtained 
were mounted on the microscope slides. The 5µ sections 
were used for histological staining with Haematoxylin and 
Eosin (H&E) technique while the 3µ sections were used for 
immunostaining of Ki-67 and p53 proteins using monoclonal 
antibody with Horseradich-peroxidise -3,3-Diaminobenzidine 
(HRP-DAB)technique.
H & E technique
The 5 µ sections were dewaxed in xylene for 15 minutes and 
hydrated with descending grades of alcohol (using 100%, 90% 
and 70% alcohol and distilled water). The tissue sections 
were stained in Haematoxylin for 10 minutes and rinsed 
under running tap water for 2 minutes. Tissue sections were 
differentiated in 1% acid alcohol for 1 minute, blued in Scott’s 
tap water for 10 minutes and rinsed in water. Tissue sections 
were stained in Eosin for 3 minutes and rinsed in water. Tissue 
sections were dehydrated with ascending grades of alcohol 
(using 70%, 90% and 100% alcohol for 2 minutes each), cleared 
in xylene for 2 minutes and mounted with distrene polystyrene 
xylene (DPX) (Fischer et al., 2008).
HRP–DAB technique
The 3 µ thick hepatic tissue sections were hydrated and antigen 
retrieval was performed by using Citric acid solution (pH 6.0) 
in a microwave at power 100 Watts and equilibrated by gently 
displacing hot Citric acid with running tap water. Endogenous 
peroxidases in sections were blocked using peroxidase block 
and sections rinsed in phosphate buffer saline (PBS).The tissue 
sections were treated with Nevocastra protein block, rinsed with 
PBS, incubated in primary antibody (1/100 dilution ratio) and 
rinsed with PBS. They were treated with secondary antibody and 
rinsed with PBS. Polymer was added to sections, allowed to dry for 
15 minutes and rinsed twice with PBS. Tissue sections were treated 
with 3, 3-Diaminobenzidine (DAB) substrate (1/100 dilution ratio) 
and rinsed with water. Tissue sections were counterstained with 
Haematoxylin and rinsed in water. Tissue sections were dehydrated, 
cleared in xylene and mounted with DPX (Omotoso et al., 2019g).
Photomicrography
All stained tissue sections were examined under the microscope 
and photomicrographs of all sections were produced using a 
10MP digital camera for the microscope. The photomicrographs 
of histological sections were examined for observable histological 
changes and immunostained photomicrographs were analyzed 
using image-J software (NIH, USA) to quantify the distribution 
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of cell proliferation (Ki-67) and tumor suppressor (p53) proteins. 
All values obtained were recorded for statistical analysis.
Statistical Analysis
Recorded values were statistically analyzed using IBM-SPSS 
version 20 (IBM Corp, USA) and presented as mean ± standard 
error of mean (SEM). Relevant statistical values were derived 
using a t-test and one-way analysis of variance. P<0.05 was 
considered as statistically significant.
RESULTS AND DISCUSSION
Histological Results
The histological profile of hepatic tissues of experimental 
animals in the treated groups 2–4 showed relatively normal 
histo-architecture which compares with the normal hepatic 
histomorphology of the control group 1 animals (Figure 1).
Immunohistochemical Results
The microscopic examination of immunohistochemical 
sections showed the distribution of Ki-67 and p53proteins in 
the parenchyma of hepatic tissues of experimental animals in 
control group 1 and treated groups 2-4 as indicated by typical 
dark-brown colouration that implied the colour product of HRP-
DAB immuno-reaction (Figures 2 and 3). Further quantitative 
analysis showed the distribution of the Ki-67 and p53 proteins 
(Figure 4).
Medicinal plants are plants with intrinsic therapeutic properties 
which can be efficiently applied in the treatment and 
management of disease conditions. The diverse therapeutic 
activities of medicinal plants extracts or herbal preparation are 
essentially a function of their constituent phytochemicals which 
Figure 1: Histological sections of hepatic tissue of controlgroup 1 and 
treated groups 2-4 (treated with 100, 300 and 500 mg/kg methanol 
extract of C. owariensis, respectively)(H&E X100). Black and green 
arrows indicate hepatic sinusoids and central veins respectively
Figure 2: HRP-DAB immunostained section of hepatic tissue of control 
group 1 and treated groups 2-4 (treated with 100, 300 and 500 mg/kg 
methanol extract of C. owariensis, respectively) (HRP-DAB X100). 
Purple and green arrows indicate Ki-67 positive sites and central 
veins respectively
Figure 3: HRP-DAB immunostained section of hepatic tissue of non-
treated control group 1 and groups 2-4 (treated with 100, 300 and 
500 mg/kg methanol extract of C. owariensis, respectively) (HRP-DAB 
X100). Blue and green arrows indicate p53 positive sites and central 
veins respectively
Figure 4: Distribution of Ki-67 (a) and p53 (b) proteins in the hepatic 
parenchyma of experimental animals treated with 100, 300 and 
500 mg/kg methanol extract of C. owariensis, respectively
a b
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are basically their secondary metabolites often referred to as 
bioactive components or active principles (Duraipandiyan et al., 
2006; Omotoso et al., 2020e; Banso and Adeyemo, 2007). These 
phytochemicals primarily confer medicinal value or therapeutic 
(including antiproliferative) activity on medicinal plant extracts 
or herbal preparations. In a study by Halabi and Shelkh (2014), 
the concentration dependent trend of antiproliferative effect 
of Cymbopogon citrates extracts was correlated with the 
phytochemical constituents of the plant. Similarly, the study 
by Amar et al., (2017) using phenolic extracts of Rosmarinus 
officinalis highlighted the antiproliferative effects of the extract 
as a function of its phytochemical properties especially the 
antioxidant activity of phenolic compounds.
According to the findings of Ekeanyanwu et al. (2012), 
the alcoholic extract of C. owariensis contains a very high 
concentration of flavonoids, saponins, tannins and fairly high 
concentration of alkaloids. These phytochemical compounds 
especially flavonoids and tannins have been described to 
exhibit diverse biological activity including antioxidant and 
antiproliferative effects (Altemimi et al., 2017; Singh et al., 2017). 
As earlier noted and in other studies by Bonofiglio et al., (2016) 
and Kabir et al., (2017), the antioxidant activity of medicinal 
plant extracts represents one of the molecular bases of their 
antiproliferative or anti-tumor effects. Furthermore, from the 
results of this study, the histological profile of hepatic tissues of 
treated experimental animals in Groups 2-4 showed no significant 
difference from the non-treated Group 1 animals (Figure 1). This 
implied no prominent changes in the hepatic histomorphology 
of the experimental animals following exposure to the plant 
extract. However, the immunohistochemical evaluation of 
proliferation markers showed a significant (p < 0.05) reduction in 
Ki-67expression and concomitant significant (p < 0.05) increase 
in p53 expression in the hepatic tissues of treated groups 2-4 
animals compared to the control group 1 animals (Figure 4).
These results revealed an inverse expression pattern of Ki-67 
and p53 proteins in the hepatic parenchyma of experimental 
animals following exposure to the plant extract. Essentially, 
these protein molecules, which are among the key markers of 
cellular proliferation and inducer of apoptosis respectively, have 
been indicated in molecular mechanisms of antiproliferative 
activity of medicinal plants (Kooti et al., 2017). On the whole, 
the mechanisms of antiproliferative effect of medicinal plants 
involve the ability of their constituent bioactive components to 
inhibit proliferation and/or activate apoptotic pathways which 
are of interest during prevention and treatment of tumorigenesis 
or carcinoma (Leelawat and Leelawat, 2017; Wang et al., 2019). 
The cell proliferation Ki-67 is one of the typical molecular 
markers of cellular proliferation which is expressed in all phases 
of cellular division within the nucleus of normal or neoplastic 
cells (Kaya et al., 2015; Jurikova et al., 2016). The inhibition of 
cellular proliferation signals leading to arrest of cell cycle and 
activation of cellular death signals leading to cellular death 
has been described as the major sub-cellular mechanisms of 
antiproliferative activity in tissues.
According to the studies by Kim et al., (2015) and Sdiri et al., 
(2018), antiproliferative mechanisms of medicinal plants 
include inhibition of AKT/mTOR and Wnt signalling pathways 
as well as down-regulation of c-myc expression and activation 
of cellular death pathways. Essentially, the down-regulation or 
inhibition of AKT/mTOR, arrest of cell cycle progression and 
induction of apoptosis have been associated with up-regulation 
of p53 expression (Li et al., 2019). Studies by Turan et al., 
(2017) and Kumnerdkhonkaen et al., (2018) also described 
the antiproliferative mechanisms to include reduction of cell 
viability, inhibition of cell cycle progression and induction 
of autophagy or apoptosis and findings by Koutsoulas et al., 
(2019) and Daddiouaissa et al., (2019) further highlighted 
antiproliferative mechanisms to involve arrest of the cell cycle 
at G0/G1 or G2/M phase. Zhang et al., (2019) also noted that 
cellular proliferation inhibition, arrest of cell cycle at G1 phase 
and induction of apoptosis due to an up-regulation of wild 
type p53 expression culminated in antiproliferative activity of 
anti-tumor agents. In essence, the inverse expression patterns 
which include the down-regulation of cell proliferation Ki-67 
and up-regulation of tumor suppressor p53 protein observed 
in this study may indicate the antiproliferative potential of 
the methanolic extracts of Cissampelos owariensis (P. Beauv.). 
However, further studies with tumorigenic cells in vivo and 
tumorigenic cell lines in vitro are required to ascertain the 
anti-proliferative activity of the plant extract and its underlying 
mechanisms.
CONCLUSION
The concomitant down-regulation of cell proliferation Ki-67 and 
up-regulation of tumor suppressor p53 protein expression in the 
hepatic parenchyma of treated experimental animals observed 
in this study may indicate antiproliferative potential or possible 
antiproliferative effect of methanolic extracts of Cissampelos 
owariensis (P. Beauv).
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